Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
Frequently asked questions
What sector does Emergent Health Corp (EMGE) operate in?
Emergent Health Corp belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Emergent Health Corp (EMGE) current stock price?
As of the latest data, Emergent Health Corp stock price is $0.00, with a previous close of $0.00.
What is Emergent Health Corp (EMGE) current market capitalization?
Emergent Health Corp market cap is approximately 42.70 thousand.
What is Emergent Health Corp (EMGE) Earnings Per Share (EPS)?
The trailing EPS is -$0.01.
Does Emergent Health Corp (EMGE) pay dividends?
No. Emergent Health Corp does not pay a dividend.
What is Emergent Health Corp (EMGE) beta (volatility) score?
Emergent Health Corp has a beta of -57.781, indicating lower volatility than the overall market.